Sign in
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Search here...
Search
Subscribe
TOP STORIES
Breaking News
Pharma Edupoint
Drug Approvals
Pharmaceutical Updates
Global Health
Dose daily
Career & Exams
Upcoming Workshop
Past Webinar
Industries
Legacies
News Now
Events
National Nutrition Month Conference 2026
Search here...
Search
Tag:
Schedule H1 Drugs
Union Health Ministry Proposes Inclusion of Four Drugs Under Schedule H1 to Tighten Regulatory Oversight
Breaking News
Dose Daily News Bureau
-
August 22, 2026
The Ministry of Health and Family Welfare (MoHFW), Department of Health and Family Welfare, has issued a draft gazette notification (G.S.R. 745(E)) proposing the...
I want in
I've read and accept the
Privacy Policy
.
Jubilant Ingrevia Enters Electronics Sector with ₹189.2 Crore Stake in Zettaone Technologies
Dose Daily News Bureau
-
August 22, 2026
Union Health Ministry Proposes Inclusion of Four Drugs Under Schedule H1 to Tighten Regulatory Oversight
Breaking News
Amylyx Pharmaceuticals Announces Positive Phase 3 Trial Results for Avexitide, for Post-Bariatric Hypoglycemia
Breaking News
Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Breaking News
Glenmark Secures U.S. FDA Approval for Flonase®️ Nasal Spray
Breaking News
Chai Discovery Collaborates with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery
Breaking News
×